CPAP与下颌前移装置对OSA健康相关生活质量影响的系统评价与网状Meta分析
本研究通过系统评价与网状Meta分析比较CPAP与下颌前移装置(MAD)对阻塞性睡眠呼吸暂停(OSA)患者健康相关生活质量的影响。共纳入23项RCT、2342例患者,结果显示CPAP较非活性对照显著改善SF-36的心理成分评分(MCS)和躯体成分评分(PCS),MAD可能同样有效,两者间无显著差异。
要点
- CPAP较非活性对照显著改善OSA患者SF-36的MCS和PCS。
- MAD对MCS和PCS的改善未达统计学显著,但可能同样有效。
- CPAP与MAD对SF-36评分的影响无统计学显著差异。
核心结论
- CPAP可有效改善OSA患者的健康相关生活质量,MAD可能同样有效,但需进一步RCT比较两者。
研究设计与样本
- 采用多变量随机效应Meta回归进行网状Meta分析,评估SF-36的MCS和PCS。
主要发现
- CPAP较非活性对照使MCS改善1.7分(95% CI,0.1-3.2;P = .036),PCS改善1.7分(95% CI,0.5-2.9;P = .005)。
- MAD较非活性对照使MCS改善2.4分(95% CI,0.0-4.9;P = .053),PCS改善1.5分(95% CI,-0.2至3.2;P = .076)。
- CPAP与MAD对SF-36评分的影响无统计学显著差异。
临床怎么用
- CPAP可考虑用于改善OSA患者的健康相关生活质量。
- MAD可作为CPAP的替代选择,尤其在不耐受CPAP时,但需个体化评估。
局限性
- 需要更多直接比较CPAP与MAD的RCT以确认两者疗效差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Untreated OSA is associated with impaired health-related quality of life (QoL) and excessive daytime sleepiness, which have been shown to improve with treatment. The aim was to compare the effects of CPAP and a mandibular advancement device (MAD) on health-related QoL in OSA. METHODS: MEDLINE and the Cochrane Library were searched up to November 2015 for randomized controlled trials (RCTs) comparing the effect of CPAP, MADs, or an inactive control treatment on health-related QoL assessed by the 36-Item Short Form Health Survey (SF-36) in OSA. Extraction of study characteristics, quality, and bias assessment were independently performed by three authors. A network meta-analysis using multivariate random-effects meta-regression was performed to assess treatment effects on the mental component score (MCS) and the physical component score (PCS) of the SF-36. RESULTS: Of 1,491 identified studies, 23 RCTs were included in the meta-analysis (2,342 patients). Compared with an inactive control, CPAP was associated with a 1.7 point (95% CI, 0.1-3.2; P = .036) improvement in the MCS and a 1.7 point (95% CI, 0.5-2.9; P = .005) improvement in the PCS. MADs were associated with a 2.4 point (95% CI, 0.0-4.9; P = .053) and a 1.5 point (95% CI, -0.2 to 3.2; P = .076) improvement in the MCS and PCS, respectively, compared with inactive control treatments. There were no statistically significant differences between treatment effects of CPAP and MAD on the SF-36 scores. CONCLUSIONS: CPAP is effective in improving health-related QoL in OSA, and MADs may be just as effective, but further RCTs comparing the two treatments are required.
引用
- Kuhn E, Schwarz EI, Bratton DJ, et al. Effects of CPAP and Mandibular Advancement Devices on Health-Related Quality of Life in OSA: A Systematic Review and Meta-analysis. Chest. 2017. PMID: 28130044. doi:10.1016/j.chest.2017.01.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。